Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Ataia
AddedFeb 16, 2024
UpdatedJun 18, 2026
Ataia

Ataia

Seed

Ataia Medical: Empowering patients with innovative communication solutions.

HQ
Roswell, GA, US
Founded
2017
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to empower patients through innovative communication solutions, Ataia Medical focuses on providing advanced tools that enable individuals to communicate more effectively. The company's core vision is to grant patients the freedom to speak, significantly improving their quality of life. Ataia Medical offers a range of communication aids designed to assist those with speech impairments, ensuring that their products are accessible and user-friendly. Their primary market focus includes healthcare providers, patients with speech disabilities, and caregivers.

Ataia Medical has garnered attention for its impactful contributions to patient care. The company has attracted notable investors and advisors from the healthcare and technology sectors, underscoring its potential for growth and innovation. Key achievements include successful product launches and positive feedback from both patients and healthcare professionals. Overall, Ataia Medical has made a significant impact by enhancing the communication capabilities of those with speech impairments, thereby improving patient outcomes and fostering greater independence.

Ataia - Similar Companies

Amptify logo

Amptify

amptify.com

Atia Vision logo

Atia Vision

atiavision.com

Speech Buddies logo

Speech Buddies

Atimize logo

Atimize

Ativa Medical logo

Ativa Medical

Voxello logo

Voxello

voxello.com

Imanyco logo

Imanyco

imanyco.com

SpeechVive logo

SpeechVive

speechvive.com

Aiva logo

Aiva

aiva.ai

AtaCor Medical logo

AtaCor Medical

atacor.com

Spoken logo

Spoken

spokenaac.com

MedRespond logo

MedRespond

medrespond.com

Atairgin Technologies logo

Atairgin Technologies

TalkMeUp logo

TalkMeUp

talkmeup.co

AudioFocus logo

AudioFocus

audiofocus.io

Ataia - Quick Facts

Who are Ataia's competitors?

Companies similar to Ataia include Amptify, Atia Vision, Speech Buddies and Atimize.

When was Ataia founded?

Ataia was founded in 2017.

Where is Ataia's headquarters located?

Ataia's headquarters is located in Roswell, GA, US.

When was Ataia's last funding round?

Ataia's most recent funding round was for $300k (USD) in July 2018.

How much has Ataia raised to-date?

As of Jul 11, 2018, Ataia has raised a total of $300k (USD).

How many employees does Ataia have?

Ataia has 7 employees as of Feb 5, 2024.

Ataia - Classification

Industry
  • Hardware
Technology
  • AI
  • Machine Learning
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Consumers
Main Product
  • Communication Aids
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 9 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 330000Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies